Abstract
Cardiac tissue engineering has a great applicable prospect in the treatment of heart disease. The hyperbranched polymer polyethylene glycol diacrylate/4-vinyl phenylboronic acid (PEGDA-PBA) and thiol hyaluronic acid (HA-SH) form an in situ hydrogel that adsorbs AST NPs to achieve drug targeting and sustained release. In addition, the composite hydrogel has certain properties of electrical stimulation through doping of gold nanorods (GNRs). In vitro studies indicated that this gel system exhibited electrical conductivity similar as a natural heart, and has a good efficacy to release drug. Our present study found that the injectable conductive hydrogel loaded with Astragaloside IV nanoparticles (AST NPs) effectively inhibited left ventricular remodeling and myocardial dysfunction after myocardial infarction (MI) in rats. HB (PEG-PBA)/HA-SH/AST NPs/GNRs also upregulated infarct margin angiogenesis, reduced cell apoptosis, and increased an expression of Connexm43 (Cx43). Thus, this bioactive injectable conductive hydrogel may provide an effective therapeutic strategy for the treatment of MI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
